TABLE 3

Stereoselective potentiation of GluN2C- and GluN2D-containing NMDARs

Values for current ratio and EC50 are mean ± S.E.M. from 8–22 oocytes obtained from at least two different frogs.

CompoundI (30 µM) / I (Control) (%)EC50 (µM) [CI]a (% Max. Modulation)
GluN2AGluN2BGluN2CGluN2DGluN2CGluN2D
(+)-FIQ100 ± 2.9102 ± 2.1192 ± 6.4177 ± 3.5NANA
(-)-FIQ97 ± 0.996 ± 0.9102 ± 3.5106 ± 4.9NENE
(+)-CIQ118 ± 1.998 ± 1.3250 ± 15285 ± 117.8 [6.8, 9.0] (286 ± 23)10.5 [9.5, 11.7] (322 ± 18)
(-)-CIQ105 ± 2.788 ± 2.7125 ± 4.7117 ± 5.6NENE
(+)-BIQ87 ± 0.599 ± 0.8318 ± 28326 ± 163.8 [3.2, 4.5] (352 ± 47)5.5 [5.1, 6.0] (354 ± 21)
(-)-BIQ89 ± 5.784 ± 0.6100 ± 5.096 ± 3.2NENE
(+)-IIQ98 ± 1.497 ± 0.7197 ± 14273 ± 152.1 [1.9, 2.2] (204 ± 16)3.5 [3.1, 4.0] (289 ± 16)
(-)-IIQ88 ± 3.685 ± 1.398 ± 5.485 ± 3.8NENE
  • a Mean half-maximally effective concentration of modulators (see Materials and Methods). The value [95% CI] was determined from fitting individual concentration-effect curves, averaging the fitted values on the log scale, and presented on linear scale. The Hill slopes ranged between 0.5 and 1.5. The fitted maximal response as a percentage of control is given in parentheses.

  • CI, confidence interval; NA, not analyzed; the concentration-effect curve could not be fitted by the Hill equation; NE, no effect; the ratio of current in 30 µM test compound to control current was less than 130%, which was our threshold for further analysis.